These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 20235886)

  • 61. LAM Cells as Potential Drivers of Senescence in Lymphangioleiomyomatosis Microenvironment.
    Bernardelli C; Ancona S; Lazzari M; Lettieri A; Selvaggio P; Massa V; Gervasini C; Di Marco F; Chiaramonte R; Lesma E
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806041
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pivotal role of augmented αB-crystallin in tumor development induced by deficient TSC1/2 complex.
    Wang F; Chen X; Li C; Sun Q; Chen Y; Wang Y; Peng H; Liu Z; Chen R; Liu K; Yan H; Ye BH; Kwiatkowski DJ; Zhang H
    Oncogene; 2014 Aug; 33(34):4352-8. PubMed ID: 24077282
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis with a TSC2 gene.
    Maruyama H; Seyama K; Sobajima J; Kitamura K; Sobajima T; Fukuda T; Hamada K; Tsutsumi M; Hino O; Konishi Y
    Mod Pathol; 2001 Jun; 14(6):609-14. PubMed ID: 11406664
    [TBL] [Abstract][Full Text] [Related]  

  • 64. CrossTORC and WNTegration in Disease: Focus on Lymphangioleiomyomatosis.
    Evans JF; Obraztsova K; Lin SM; Krymskaya VP
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668092
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase.
    Roux PP; Ballif BA; Anjum R; Gygi SP; Blenis J
    Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13489-94. PubMed ID: 15342917
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis.
    Yu J; Astrinidis A; Henske EP
    Am J Respir Crit Care Med; 2001 Oct; 164(8 Pt 1):1537-40. PubMed ID: 11704609
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Anti-EGFR antibody reduces lung nodules by inhibition of EGFR-pathway in a model of lymphangioleiomyomatosis.
    Lesma E; Chiaramonte E; Ancona S; Orpianesi E; Di Giulio AM; Gorio A
    Biomed Res Int; 2015; 2015():315240. PubMed ID: 25699271
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management.
    McCarthy C; Gupta N; Johnson SR; Yu JJ; McCormack FX
    Lancet Respir Med; 2021 Nov; 9(11):1313-1327. PubMed ID: 34461049
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Sphingolipid, fatty acid and phospholipid metabolites are associated with disease severity and mTOR inhibition in lymphangioleiomyomatosis.
    Bottolo L; Miller S; Johnson SR
    Thorax; 2020 Aug; 75(8):679-688. PubMed ID: 32467337
    [TBL] [Abstract][Full Text] [Related]  

  • 70. TSC1 and TSC2 mutations in patients with lymphangioleiomyomatosis and tuberous sclerosis complex.
    Muzykewicz DA; Sharma A; Muse V; Numis AL; Rajagopal J; Thiele EA
    J Med Genet; 2009 Jul; 46(7):465-8. PubMed ID: 19419980
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Neutrophil elastase from myeloid cells promotes TSC2-null tumor growth.
    Taya M; Garcia-Hernandez ML; Rangel-Moreno J; Minor B; Gibbons E; Hammes SR
    Endocr Relat Cancer; 2020 Apr; 27(4):261-274. PubMed ID: 32045362
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lymphangioleiomyomatosis screening in women with tuberous sclerosis.
    Cudzilo CJ; Szczesniak RD; Brody AS; Rattan MS; Krueger DA; Bissler JJ; Franz DN; McCormack FX; Young LR
    Chest; 2013 Aug; 144(2):578-585. PubMed ID: 23539171
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Detection of low-prevalence somatic TSC2 mutations in sporadic pulmonary lymphangioleiomyomatosis tissues by deep sequencing.
    Fujita A; Ando K; Kobayashi E; Mitani K; Okudera K; Nakashima M; Miyatake S; Tsurusaki Y; Saitsu H; Seyama K; Miyake N; Matsumoto N
    Hum Genet; 2016 Jan; 135(1):61-8. PubMed ID: 26563443
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Single-cell multiomic analysis identifies a HOX-PBX gene network regulating the survival of lymphangioleiomyomatosis cells.
    Olatoke T; Wagner A; Astrinidis A; Zhang EY; Guo M; Zhang AG; Mattam U; Kopras EJ; Gupta N; Smith EP; Karbowniczek M; Markiewski MM; Wikenheiser-Brokamp KA; Whitsett JA; McCormack FX; Xu Y; Yu JJ
    Sci Adv; 2023 May; 9(19):eadf8549. PubMed ID: 37163604
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Possible Novel Therapeutic Targets in Lymphangioleiomyomatosis Treatment.
    Song X; Cai H; Yang C; Xue X; Wang J; Mo Y; Zhu M; Zhu G; Ye L; Jin M
    Front Med (Lausanne); 2020; 7():554134. PubMed ID: 33072782
    [TBL] [Abstract][Full Text] [Related]  

  • 76. mTOR signaling in the control of activation of primordial follicles.
    Adhikari D; Liu K
    Cell Cycle; 2010 May; 9(9):1673-4. PubMed ID: 20404510
    [No Abstract]   [Full Text] [Related]  

  • 77. Cross-talk between tuberin, calmodulin, and estrogen signaling pathways.
    York B; Lou D; Panettieri RA; Krymskaya VP; Vanaman TC; Noonan DJ
    FASEB J; 2005 Jul; 19(9):1202-4. PubMed ID: 15851513
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The efficacy and adverse events of mTOR inhibitors in lymphangioleiomyomatosis: systematic review and meta-analysis.
    Gao N; Zhang T; Ji J; Xu KF; Tian X
    Orphanet J Rare Dis; 2018 Aug; 13(1):134. PubMed ID: 30107845
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A survey of use of mTOR inhibitors in patients with lymphangioleiomyomatosis listed for lung transplant.
    Warrior K; Leard LE; Nair AR; Gries CJ; Fisher AJ; Johnson SR; McCormack FX; Dilling DF
    Respir Med; 2022; 195():106779. PubMed ID: 35276437
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Risk of breast cancer in patients with lymphangioleiomyomatosis.
    Nuñez O; Baldi BG; Radzikowska E; Carvalho CRR; Herranz C; Sobiecka M; Torre O; Harari S; Vergeer MAMH; Kolbe J; Pollán M; Pujana MA
    Cancer Epidemiol; 2019 Aug; 61():154-156. PubMed ID: 31260937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.